Chuang Lea-Yea, Guh Jinn-Yuh, Liu Shu-Fen, Hung Min-Yuan, Liao Tung-Nan, Chiang Tai-An, Huang Jau-Shyang, Huang Yu-Lun, Lin Chi-Fong, Yang Yu-Lin
Department of Biochemistry, Kaohsiung Medical University, Tainan, Taiwan.
Biochem J. 2003 Oct 15;375(Pt 2):385-93. doi: 10.1042/BJ20030522.
TGF-beta (transforming growth factor-beta) is implicated in the pathogenesis of diabetic nephropathy. We previously demonstrated that up-regulation of type II TGF-beta receptor (TbetaRII) induced by high glucose might contribute to distal tubular hypertrophy [Yang, Guh, Yang, Lai, Tsai, Hung, Chang and Chuang (1998) J. Am. Soc. Nephrol. 9, 182-193]. We have elucidated the mechanism by using cultured Madin-Darby canine kidney cells. Enhancer assay and electrophoretic-mobility-shift assay were used to estimate the involvement of transcription factors. Western blotting and an in vitro kinase assay were used to evaluate the level and activity of protein kinase. We showed that glucose (100-900 mg/dl) induced an increase in mRNA level and promoter activity of TbetaRII (note: 'mg/dl' are the units commonly used in diabetes studies). The promoter region -209 to -177 appeared to contribute to positive transactivation of TbetaRII promoter by comparing five TbetaRII-promoter-CAT (chloramphenicol acetyl-transferase) plasmids. Moreover, the transcription factor AP-1 (activator protein 1) was significantly activated and specifically binds to TbetaRII promoter (-209 to -177). More importantly, we found that atypical PKC iota might be pivotal for high glucose-induced increase in both AP-1 binding and TbetaRII promoter activity. First, high glucose induced cytosolic translocation, activation and autophosphorylation of PKC iota. Secondly, antisense PKC iota expression plasmids attenuated high-glucose-induced increase in AP-1 binding and TbetaRII promoter activity; moreover, sense PKC iota expression plasmids enhanced these instead. Finally, we showed that antisense PKC iota expression plasmids might partly attenuate a high-glucose/TGF-beta1-induced increase in fibronectin. We conclude that PKC iota might mediate high-glucose-induced increase in TbetaRII promoter activity. In addition, antisense PKC iota expression plasmid effectively suppressed up-regulation of TbetaRII and fibronectin in hyperglycaemic distal-tubule cells.
转化生长因子β(TGF-β)与糖尿病肾病的发病机制有关。我们之前证明,高糖诱导的II型TGF-β受体(TβRII)上调可能导致远端肾小管肥大[Yang, Guh, Yang, Lai, Tsai, Hung, Chang和Chuang(1998年)《美国肾脏病学会杂志》9, 182 - 193]。我们利用培养的Madin-Darby犬肾细胞阐明了其机制。采用增强子分析和电泳迁移率变动分析来评估转录因子的参与情况。利用蛋白质印迹法和体外激酶分析来评估蛋白激酶的水平和活性。我们发现,葡萄糖(100 - 900毫克/分升)可诱导TβRII的mRNA水平和启动子活性增加(注意:“毫克/分升”是糖尿病研究中常用的单位)。通过比较五个TβRII启动子 - 氯霉素乙酰转移酶(CAT)质粒,启动子区域 - 209至 - 177似乎对TβRII启动子的正向反式激活有作用。此外,转录因子AP - 1(激活蛋白1)被显著激活,并特异性结合到TβRII启动子( - 209至 - 177)。更重要的是,我们发现非典型蛋白激酶Cι可能对高糖诱导的AP - 1结合增加和TβRII启动子活性增加起关键作用。首先,高糖诱导蛋白激酶Cι的胞质转位、激活和自磷酸化。其次,反义蛋白激酶Cι表达质粒减弱了高糖诱导的AP - 1结合增加和TβRII启动子活性;此外,正义蛋白激酶Cι表达质粒则增强了这些作用。最后,我们表明反义蛋白激酶Cι表达质粒可能部分减弱高糖/TGF-β1诱导的纤连蛋白增加。我们得出结论,蛋白激酶Cι可能介导高糖诱导的TβRII启动子活性增加。此外,反义蛋白激酶Cι表达质粒有效抑制了高血糖远端小管细胞中TβRII和纤连蛋白的上调。